Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "racial disparities"

GrantNIH REPORTERMay 11

New NIH Grant: Accelerated Biological Aging and Immunosenescence as Drivers for Racial Disparities in Monoclonal Ga — $558K at Unknown Institution

Researchers are studying why multiple myeloma and a related blood condition called MGUS are more common in African American patients. Scientists received $558,000 to investigate whether faster aging of the immune system might explain these differences. Interestingly, when African American patients get equal healthcare access, they actually do better than other groups, which suggests biology and healthcare access both play a role.

WHY IT MATTERSThis research directly addresses why African American patients develop multiple myeloma at higher rates, which could lead to earlier screening and better prevention strategies for this high-risk population.
Good to knowMultiple MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases